Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide

Therapie. 2022 May-Jun;77(3):386-388. doi: 10.1016/j.therap.2021.04.009. Epub 2021 Apr 24.

Authors

Mathilde Bérard¹, Marina Babin², Delphine Bourneau-Martin², Christian Le Clec'h³

Affiliations

¹ Service de dermatologie, CHU Angers, 4, rue Larrey, 49000 Angers, France. Electronic address: mathberard@hotmail.fr.
² Service de pharmacovigilance, CHU Angers, 4 rue Larrey, 49000 Angers, France.
³ Service de dermatologie, CHU Angers, 4, rue Larrey, 49000 Angers, France.

PMID: 34740446
DOI: 10.1016/j.therap.2021.04.009

No abstract available

Keywords: Clinical pharmacology; Dermatology; Drugs; Octreotide; Pharmacovigilance.

Publication types

Case Reports
Letter

MeSH terms

Delayed-Action Preparations / adverse effects
Drug Eruptions* / etiology
Humans
Injections, Intramuscular
Nicolau Syndrome* / etiology
Octreotide / adverse effects

Substances

Delayed-Action Preparations
Octreotide